Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained ...
Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from ...
The Pancreatic Cancer Action Network is holding a webinar “Nutrition and Pancreatic Cancer: Weight Loss, Enzymes and More” to talk about common nutritional challenges related to pancreatic cancer.
Researchers launch a public immune atlas of pancreatic cancer therapy responses, allowing the public to rapidly link pancreatic cancer immunotherapy trials to immune shifts and outcomes. Imagine ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, to ...
A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...
Now, a Carnegie Mellon University spinout company aims to identify patients at high risk for lung, liver and pancreatic ...
On a recent morning, Lida Feller and Jerry Sanders were busy working at the new Jacksonville Historical Museum. The museum, which had been closed for about two years, recently reopened at a new ...
A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
Pancreatic cancer is one of the most dangerous forms of cancer in the world. Doctors and scientists have struggled for many years to find effective treatments for it. Many patients are diagnosed at a ...
Morning Overview on MSN
AI blood test spots early pancreatic cancer with up to 94% accuracy
Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results